Post-infectious irritable bowel syndrome: Mechanistic insights into chronic disturbances following enteric infection

World Journal of Gastroenterology

Volumn 20, Issue 14, 2014, Pages 3976-3985

  Beatty, Jennifer K ^a   Bhargava, Amol ^a   Buret, Andre G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Enteric pathogen; Immune alterations; Infectious diarrhea; Inflammatory disorders; Post infectious irritable bowel syndrome

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; CYTOKINE;

DENDRITIC CELL; ENTEROCHROMAFFIN CELL; ESCHERICHIA COLI; GASTROINTESTINAL MOTILITY; HUMAN; HYPERSENSITIVITY; INFLAMMATION; INTESTINE FLORA; INTESTINE INFECTION; IRRITABLE COLON; MACROPHAGE; MAST CELL; MOLECULAR PATHOLOGY; NONHUMAN; PHAGOCYTOSIS; REVIEW; COMPLICATION; CYTOLOGY; DIARRHEA; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; PATHOLOGY; STOMACH DISEASE;

CYTOKINES; DENDRITIC CELLS; DIARRHEA; ENTEROCHROMAFFIN CELLS; HUMANS; INFLAMMATION; INTESTINES; IRRITABLE BOWEL SYNDROME; MACROPHAGES; MAST CELLS; MICROBIOTA; STOMACH DISEASES;

EID: 84898431606     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i14.3976     Document Type: Review

References (101)

1. Bixquert Jiménez M. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last? Rev Esp Enferm Dig 2009; 101: 553-564 [PMID: 19785495]
2. Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol 2006; 22: 13-17 [PMID: 16319671]
3. Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil 2013; 19: 301-311 [PMID: 23875096 DOI: 10.5056/jnm.2013.19.3.301]
4. Ford AC, Talley NJ. IBS in 2010: advances in pathophysiology, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 2011; 8: 76-78 [PMID: 21293507 DOI: 10.1038/nrgastro. 2010.216]
5. Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163-173 [PMID: 20101257 DOI: 10.1038/nrgastro.2010.4]
6. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-1988 [PMID: 19457422 DOI: 10.1053/j.gastro.2009.02.074]
7. Zhou Q, Verne GN. New insights into visceral hypersensitivity-- clinical implications in IBS. Nat Rev Gastroenterol Hepatol 2011; 8: 349-355 [PMID: 21643039 DOI: 10.1038/ nrgastro.2011.83]
8. Zhou Q, Fillingim RB, Riley JL, Malarkey WB, Verne GN. Central and peripheral hypersensitivity in the irritable bowel syndrome. Pain 2010; 148: 454-461 [PMID: 20074857 DOI: 10.1016/j.pain.2009.12.005]
9. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000; 47: 804-811 [PMID: 11076879]
10. Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 2003; 125: 1651-1659 [PMID: 14724817]
11. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003; 98: 1578-1583 [PMID: 12873581 DOI: 10.1111/j.1572-0241.2003.07542.x]
12. Zanini B, Ricci C, Bandera F, Caselani F, Magni A, Laronga AM, Lanzini A. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak. Am J Gastroenterol 2012; 107: 891-899 [PMID: 22525306 DOI: 10.1038/ ajg.2012.102]
13. Bercík P, Wang L, Verdú EF, Mao YK, Blennerhassett P, Khan WI, Kean I, Tougas G, Collins SM. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology 2004; 127: 179-187 [PMID: 15236184]
14. Parry SD, Stansfield R, Jelley D, Gregory W, Phillips E, Barton JR, Welfare MR. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 2003; 98: 1970-1975 [PMID: 14499773 DOI: 10.1111/j.1572-0241.2003.07664.x]
15. Ji S, Park H, Lee D, Song YK, Choi JP, Lee SI. Post-infectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005; 20: 381-386 [PMID: 15740480 DOI: 10.1111/j.1440-1746.2005.03574.x]
16. Kim HS, Kim MS, Ji SW, Park H. [The development of irritable bowel syndrome after Shigella infection: 3 year followup study]. Korean J Gastroenterol 2006; 47: 300-305 [PMID: 16632982]
17. Wang H, Chang L. The Walkerton outbreak revisited at year 8: predictors, prevalence, and prognosis of postinfectious irritable bowel syndrome. Gastroenterology 2011; 140: 726-78; discussion 726-78; [PMID: 21182958 DOI: 10.1053/ j.gastro.2010.12.008]
18. Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol 2009; 9: 27 [PMID: 19383162 DOI: 10.1186/1471-230X-9-27]
19. Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol 2009; 15: 3591-3596 [PMID: 19653335]
20. Villani AC, Lemire M, Thabane M, Belisle A, Geneau G, Garg AX, Clark WF, Moayyedi P, Collins SM, Franchimont D, Marshall JK. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138: 1502-1513 [PMID: 20044998 DOI: 10.1053/j.gastro.2009.12.049]
21. Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159-176 [PMID: 22730468 DOI: 10.1136/gutjnl-2012-302167]
22. Posserud I, Ersryd A, Simrén M. Functional findings in irritable bowel syndrome. World J Gastroenterol 2006; 12: 2830-2838 [PMID: 16718806]
23. Small PK, Loudon MA, Hau CM, Noor N, Campbell FC. Large-scale ambulatory study of postprandial jejunal motility in irritable bowel syndrome. Scand J Gastroenterol 1997; 32: 39-47 [PMID: 9018765]
24. Ng C, Danta M, Kellow J, Badcock CA, Hansen R, Malcolm A. Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2005; 289: G489-G494 [PMID: 15905412 DOI: 10.1152/ajpgi.00527.2004]
25. Akiho H, Deng Y, Blennerhassett P, Kanbayashi H, Collins SM. Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology 2005; 129: 131-141 [PMID: 16012943]
26. Akiho H, Blennerhassett P, Deng Y, Collins SM. Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 2002; 282: G226-G232 [PMID: 11804843]
27. Qin HY, Wu JC, Tong XD, Sung JJ, Xu HX, Bian ZX. Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome. J Gastroenterol 2011; 46: 164-174 [PMID: 20848144 DOI: 10.1007/s00535-010-0321-6]
28. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2001; 93: 7-14 [PMID: 11406333]
29. Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2011; 25: 386-394 [PMID: 21094682 DOI: 10.1016/j.bbi.2010.11.010]
30. Elsenbruch S, Rosenberger C, Enck P, Forsting M, Schedlowski M, Gizewski ER. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut 2010; 59: 489-495 [PMID: 19651629 DOI: 10.1136/gut.2008.175000]
31. Zhou Q, Price DD, Caudle RM, Verne GN. Visceral and somatic hypersensitivity in a subset of rats following TNBSinduced colitis. Pain 2008; 134: 9-15 [PMID: 17481818 DOI: 10.1016/j.pain.2007.03.029]
32. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002; 122: 1778-1783 [PMID: 12055584]
33. Törnblom H, Lindberg G, Nyberg B, Veress B. Fullthickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002; 123: 1972-1979 [PMID: 12454854 DOI: 10.1053/ gast.2002.37059]
34. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53: 1096-1101 [PMID: 15247174 DOI: 10.1136/ gut.2003.021154]
35. Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E, Malagelada JR. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007; 56: 203-209 [PMID: 17005763 DOI: 10.1136/gut.2006.100594]
36. Walker MM, Talley NJ, Prabhakar M, Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009; 29: 765-773 [PMID: 19183150 DOI: 10.1111/j.1365-2036.2009.03937.x]
37. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702 [PMID: 14988823]
38. Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007; 132: 26-37 [PMID: 17241857 DOI: 10.1053/j.gastro.2006.11.039]
39. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, O'Morain CA. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12: 449-457 [PMID: 11012945]
40. Rijnierse A, Nijkamp FP, Kraneveld AD. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther 2007; 116: 207-235 [PMID: 17719089 DOI: 10.1016/j.pharmth era.2007.06.008]
41. Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol 2006; 21: 71-78 [PMID: 16706815 DOI: 10.1111/j.1440-1746.2005.04143.x]
42. Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009; 104: 392-400 [PMID: 19174797 DOI: 10.1038/ajg.2008.94]
43. Long Y, Wang W, Wang H, Hao L, Qian W, Hou X. Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome. J Gastroenterol Hepatol 2012; 27: 935-944 [PMID: 22141367 DOI: 10.1111/j.1440-1746.2011.07046.x]
44. Suzuki T, Franchi L, Toma C, Ashida H, Ogawa M, Yoshikawa Y, Mimuro H, Inohara N, Sasakawa C, Nuñez G. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog 2007; 3: e111 [PMID: 17696608 DOI: 10.1371/journal.ppat.0030111]
45. Sasakawa C. A new paradigm of bacteria-gut interplay brought through the study of Shigella. Proc Jpn Acad Ser B Phys Biol Sci 2010; 86: 229-243 [PMID: 20228623]
46. Kindt S, Van Oudenhove L, Broekaert D, Kasran A, Ceuppens JL, Bossuyt X, Fischler B, Tack J. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009; 21: 389-398 [PMID: 19126184 DOI: 10.1111/j.1365-2982.2008.01220.x]
47. Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913-920 [PMID: 17383420 DOI: 10.1053/j.gastro.2007.01.046]
48. Miao EA, Rajan JV. Salmonella and Caspase-1: A complex Interplay of Detection and Evasion. Front Microbiol 2011; 2: 85 [PMID: 21833326 DOI: 10.3389/fmicb.2011.00085]
49. Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjövall H, Simrén M. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104: 1205-1212 [PMID: 19367268 DOI: 10.1038/ajg.2009.116]
50. Hickey TE, McVeigh AL, Scott DA, Michielutti RE, Bixby A, Carroll SA, Bourgeois AL, Guerry P. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin- 8 from intestinal epithelial cells. Infect Immun 2000; 68: 6535-6541 [PMID: 11083762]
51. Young KT, Davis LM, Dirita VJ. Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 2007; 5: 665-679 [PMID: 17703225 DOI: 10.1038/nrmicro1718]
52. O'Hara JR, Feener TD, Fischer CD, Buret AG. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice. Infect Immun 2012; 80: 1563-1571 [PMID: 22311925 DOI: 10.1128/ IAI.06066-11]
53. Kalischuk LD, Leggett F, Inglis GD. Campylobacter jejuni induces transcytosis of commensal bacteria across the intestinal epithelium through M-like cells. Gut Pathog 2010; 2: 14 [PMID: 21040540 DOI: 10.1186/1757-4749-2-14]
54. Kalischuk LD, Inglis GD, Buret AG. Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Gut Pathog 2009; 1: 2 [PMID: 19338680 DOI: 10.1186/1757-4749-1-2]
55. Sharma R, Tesfay S, Tomson FL, Kanteti RP, Viswanathan VK, Hecht G. Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastro- intest Liver Physiol 2006; 290: G685-G694 [PMID: 16322091 DOI: 10.1152/ajpgi.00404.2005]
56. Savkovic SD, Koutsouris A, Hecht G. Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol 1997; 273: C1160-C1167 [PMID: 9357759]
57. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003; 171: 6164-6172 [PMID: 14634132]
58. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA, Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 2005; 19: 923-933 [PMID: 15923402 DOI: 10.1096/fj.04-3260com]
59. Al-Sadi RM, Ma TY. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 2007; 178: 4641-4649 [PMID: 17372023]
60. Bashashati M, Rezaei N, Andrews CN, Chen CQ, Daryani NE, Sharkey KA, Storr MA. Cytokines and irritable bowel syndrome: where do we stand? Cytokine 2012; 57: 201-209 [PMID: 22178716 DOI: 10.1016/j.cyto.2011.11.019]
61. Scully P, McKernan DP, Keohane J, Groeger D, Shanahan F, Dinan TG, Quigley EM. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010; 105: 2235-2243 [PMID: 20407431 DOI: 10.1038/ajg.2010.159]
62. Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, Tiesman J, Fulmer A, Kiely B, Dinan TG, Shanahan F, Quigley EM. Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol 2008; 43: 1467-1476 [PMID: 18752146 DOI: 10.1080/00365520802276127]
63. Guttman JA, Samji FN, Li Y, Vogl AW, Finlay BB. Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo. Infect Immun 2006; 74: 6075-6084 [PMID: 16954399 DOI: 10.1128/IAI.00721-06]
64. Lapointe TK, O'Connor PM, Buret AG. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrhea. Lab Invest 2009; 89: 964-970 [PMID: 19620958 DOI: 10.1038/labinvest.2009.69]
65. Marshall JK, Thabane M, Garg AX, Clark W, Meddings J, Collins SM. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther 2004; 20: 1317-1322 [PMID: 15606393 DOI: 10.1111/ j.1365-2036.2004.02284.x]
66. Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol 2006; 101: 1288-1294 [PMID: 16771951 DOI: 10.1111/j.1572-0241.2006.00672.x]
67. Roxas JL, Koutsouris A, Bellmeyer A, Tesfay S, Royan S, Falzari K, Harris A, Cheng H, Rhee KJ, Hecht G. Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Lab Invest 2010; 90: 1152-1168 [PMID: 20479715 DOI: 10.1038/labinvest.2010.91]
68. Flynn AN, Wang A, McKay DM, Buret AG. Apoptosis-inducing factor contributes to epithelial cell apoptosis induced by enteropathogenic Escherichia coli. Can J Physiol Pharmacol 2011; 89: 143-148 [PMID: 21326346 DOI: 10.1139/y11-002]
69. O'Brien AO, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli O157: H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet 1983; 1: 702 [PMID: 6132054]
70. Manjarrez-Hernandez HA, Baldwin TJ, Williams PH, Haigh R, Knutton S, Aitken A. Phosphorylation of myosin light chain at distinct sites and its association with the cytoskeleton during enteropathogenic Escherichia coli infection. Infect Immun 1996; 64: 2368-2370 [PMID: 8675355]
71. Philpott DJ, McKay DM, Mak W, Perdue MH, Sherman PM. Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability. Infect Immun 1998; 66: 1680-1687 [PMID: 9529098]
72. Yuhan R, Koutsouris A, Savkovic SD, Hecht G. Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. Gastroenterology 1997; 113: 1873-1882 [PMID: 9394726]
73. Wensaas KA, Langeland N, Hanevik K, Mørch K, Eide GE, Rortveit G. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut 2012; 61: 214-219 [PMID: 21911849 DOI: 10.1136/gutjnl-2011-300220]
74. Cotton JA, Beatty JK, Buret AG. Host parasite interactions and pathophysiology in Giardia infections. Int J Parasitol 2011; 41: 925-933 [PMID: 21683702 DOI: 10.1016/j.ijpara.2011.05.002]
75. Teoh DA, Kamieniecki D, Pang G, Buret AG. Giardia lamblia rearranges F-actin and alpha-actinin in human colonic and duodenal monolayers and reduces transepithelial electrical resistance. J Parasitol 2000; 86: 800-806 [PMID: 10958459 DOI: 10.1645/0022-3395(2000)086[0800:GLRFAA]2.0.CO;2]
76. Buret AG, Mitchell K, Muench DG, Scott KG. Giardia lamblia disrupts tight junctional ZO-1 and increases permeability in non-transformed human small intestinal epithelial monolayers: effects of epidermal growth factor. Parasitology 2002; 125: 11-19 [PMID: 12166516]
77. Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009; 58: 196-201 [PMID: 18824556 DOI: 10.1136/gut.2007.140806]
78. Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztóczy A, Izbéki F, Fioramonti J, Wittmann T, Bueno L. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 2008; 57: 591-599 [PMID: 18194983 DOI: 10.1136/gut.2007.140210]
79. Navarro-García F, Canizalez-Roman A, Sui BQ, Nataro JP, Azamar Y. The serine protease motif of EspC from enteropathogenic Escherichia coli produces epithelial damage by a mechanism different from that of Pet toxin from enteroaggregative E. coli. Infect Immun 2004; 72: 3609-3621 [PMID: 15155671 DOI: 10.1128/IAI.72.6.3609-3621.2004]
80. Steck N, Hoffmann M, Sava IG, Kim SC, Hahne H, Tonkonogy SL, Mair K, Krueger D, Pruteanu M, Shanahan F, Vogelmann R, Schemann M, Kuster B, Sartor RB, Haller D. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 2011; 141: 959-971 [PMID: 21699778 DOI: 10.1053/j.gastro.2011.05.035]
81. Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW, Sharkey KA, Ferraz JG, Shaffer E, Vergnolle N. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007; 117: 636-647 [PMID: 17304351 DOI: 10.1172/JCI29255]
82. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM, Moses PL. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 126: 1657-1664 [PMID: 15188158]
83. Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3: 349-357 [PMID: 15822040]
84. Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006; 130: 34-43 [PMID: 16401466 DOI: 10.1053/j.gastro.2005.09.031]
85. Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clin Chim Acta 2009; 403: 47-55 [PMID: 19361459 DOI: 10.1016/ j.cca.2009.01.028]
86. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005; 17: 863-870 [PMID: 16336502 DOI: 10.1111/j.1365-2982.2005.00719.x]
87. Dizdar V, Spiller R, Singh G, Hanevik K, Gilja OH, El-Salhy M, Hausken T. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010; 31: 883-891 [PMID: 20132151 DOI: 10.1111/j.1365-2036.2010.04251.x]
88. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10: 159-169 [PMID: 20182457 DOI: 10.1038/ nri2710]
89. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-14696 [PMID: 20679230 DOI: 10.1073/pnas.1005963107]
90. Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology 2010; 156: 3205-3215 [PMID: 20705664 DOI: 10.1099/mic.0.043257-0]
91. Rajilić-Stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1792-1801 [PMID: 21820992 DOI: 10.1053/ j.gastro.2011.07.043]
92. Carroll IM, Ringel-Kulka T, Keku TO, Chang YH, Packey CD, Sartor RB, Ringel Y. Molecular analysis of the luminaland mucosal-associated intestinal microbiota in diarrheapredominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2011; 301: G799-G807 [PMID: 21737778 DOI: 10.1152/ajpgi.00154.2011]
93. Pimentel M, Chatterjee S, Chang C, Low K, Song Y, Liu C, Morales W, Ali L, Lezcano S, Conklin J, Finegold S. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci 2008; 53: 982-989 [PMID: 17934822 DOI: 10.1007/s10620-007-9977-z]
94. Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, Salzman N. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 2008; 76: 907-915 [PMID: 18160481 DOI: 10.1128/IAI.01432-07]
95. Andre G, Buret SVA, Feener T, McKnight G, Wallace J, Rioux K, Beatty JK. Campylobacter Jejunior Giardia duodenalis- Mediated Disruptions of Human Intestinal Microbiota Biofilms: Novel Mechanisms Producing Post-Infectious Intestinal Inflammatory Disorders? Gastroenterology 2013; 144: s-309
96. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2: 204 [PMID: 18030708]
97. Cotter PD, Stanton C, Ross RP, Hill C. The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing. Discov Med 2012; 13: 193-199 [PMID: 22463795]
98. Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut 2007; 56: 1066-1071 [PMID: 17324974 DOI: 10.1136/gut.2006.108811]
99. Han B. Correlation between gastrointestinal hormones and anxiety-depressive states in irritable bowel syndrome. Exp Ther Med 2013; 6: 715-720 [PMID: 24137253 DOI: 10.3892/ etm.2013.1211]
100. Kiank C, Taché Y, Larauche M. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin- releasing factor receptors. Brain Behav Immun 2010; 24: 41-48 [PMID: 19698778 DOI: 10.1016/j.bbi.2009.08.006]
101. O'Mahony SM, Hyland NP, Dinan TG, Cryan JF. Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl) 2011; 214: 71-88 [PMID: 20886335 DOI: 10.1007/s00213-010-2010-9]